From The Hobbit to Percy Jackson, these films are based on books, but are all but too disconnected from them to be ...

From legendary heroes to voices that shaped generations, New Zealand’s biggest pop-culture stage, Armageddon Expo, comes ...

Serena & Lily and Lilly Pulitzer collaborated on a holiday-themed tablescape for a "Dress the Table" event in Palm Beach. The design combined Serena & Lily's calming style with Lilly Pulitzer's ...

Eli Lilly is a leader in weight loss drugs, a market that may reach $95 billion by the end of the decade. Viking Therapeutics is heading toward the finish line with a drug that could compete with ...

Palm Beach's council has rejected a proposal for a historical marker honoring fashion icon Lilly Pulitzer. Council members raised concerns about the sign's proposed location, size and the precedent of ...

Bringing the machine to life. Back in May, Eric Church performed two shows at The Pinnacle in Nashville to celebrate the release of his latest album, Evangeline vs. The Machine. The album was ...

Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking up wins against placebo and AstraZeneca’s Farxiga to stay on track to seek ...

Eli Lilly said its investigational oral GLP-1 weight-loss drug, orforglipron, met its primary endpoints in two recent phase 3 trials. The medicine company said Wednesday the drug met the primary and ...

Agnes “Kit” Racine, 91, of Winooski, Vermont went home peacefully to the Lord on September 23, 2025, at the Respite House in Colchester, Vermont with family by her side, ending a 4 year bout with ...

Eight highly-accomplished Hancock County students recently received a call that could make an indelible impact on their futures. All eight have been selected as finalists for next year’s Lilly ...

Eli Lilly: Was I Too Cautious? We don't get everything right, do we? While I nailed the upgrade in Eli Lilly and Company (NYSE:LLY) stock in my last write-up in August, some of you might contend that ...

Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to be presented as a late-breaking oral ...